On 6 Nov 2026, NACL Industries was priced at ₹117.21, or 234.4× trailing earnings, against an industry P/E of 14.4×, and the shares are 52% below their 52-week high. Sales and net profit fell 9.1% and 64% a year over 3 years; its ROCE of 6.9% is the lowest among the 7 largest Agricultural Inputs peers. Debt is 0.46× equity. It is a small-cap company with a market cap of ₹2,746 Cr, ranked 19th of 72 Agricultural Inputs companies by market cap; the shares fell 33% over the past year.
- ₹133.51
- ₹133.51
- ₹114.23
- ₹134.21
- 35.9 L
Health check
- ReturnsBehind
−32.7% over a year, better than 2 of 7 peers.
- Price tagPricier
P/E 234.4 vs industry 14.4.
- GrowthShrinking
Sales −9.1%, profit −63.6% a year over 3 years.
- ProfitabilityWeak
ROCE 6.9% vs peer median 20.9%.
- Balance sheetStretched
Debt 0.46× equity, interest covered 1.2×, Piotroski 5 of 9.
- Red flags5 to check
Return on equity is low at 0.8%.
Small cap
Defensive
Key metrics
- Market cap
- ₹2,746 Cr
- Small cap
- P/E
- 234.4
- Industry 14.4
- Price to book
- 4.02
- Peers 4.28
- Dividend yield
- 0.00%
- ROE
- 0.8%
- Peers 16.2%
- ROCE
- 6.9%
- Peers 20.9%
- Debt to equity
- 0.46
- Debt ₹312 Cr
- EPS (TTM)
- ₹0.50
- Face value ₹1
- OPM (TTM)
- 8.5%
- Net margin 0.8%
- Sales growth
- −14.5%
- Latest quarter vs a year ago
- Profit growth
- +59.8%
- Latest quarter vs a year ago
- Price to sales
- 1.81
- EV/EBITDA 30.8
Strengths and risks
Strengths
- Quarterly profit up 59.8% on a year ago.
Risks to check
- Return on equity is low at 0.8%.
- Quarterly sales down 14.5% on a year ago.
- P/E of 234.4 against an industry P/E of 14.4.
- 52% below its 52-week high.
- Interest coverage of only 2.0×.
About NACL Industries
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, difenoconazole, thifluzamide, bispyribac sodium, clodinafop propargyl, metribuzin, quizalofop ethyl, haloxyfop r methyl, and glufosinate ammonium; and formulations, such as…
- Headquarters
- Hyderabad
- Employees
- 1,294
- Sector
- Basic Materials
- ISIN
- INE295D01020
- Website
- naclind.com
Price range
- Avg volume (3M)
- 5.3 L
- 1-year return
- minus 32.7%
- From 52-week high
- minus 52.2%
Peers · Agricultural Inputs
| Company | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| COROMANDELCoromandel International | 1,824.00 | minus 4.00% | 53,724 | 34.5 | 17.0 | 20.9% | 9.4% | 0.11 | 10.2% | minus 12.4% |
| FACTFertilisers and Chemicals Travancore | 750.25 | minus 1.24% | 48,547 | – | 703.5 | 14.2% | 0.0% | 2.95 | 0.0% | minus 15.3% |
| UPLUPL | 534.90 | plus 1.60% | 45,214 | 23.9 | 6.0 | 9.9% | 20.0% | 0.83 | −1.2% | minus 28.0% |
| PIINDPI Industries | 1,735.00 | minus 1.98% | 26,321 | 30.0 | 13.1 | 14.7% | 24.2% | 0.03 | 1.1% | minus 51.9% |
| SUMICHEMSumitomo Chemical India | 328.95 | plus 0.34% | 16,419 | 29.4 | 21.0 | 21.0% | 20.3% | 0.02 | −2.6% | minus 34.4% |
| CHAMBLFERTChambal Fertilizers & Chemicals | 384.70 | minus 0.91% | 15,413 | 8.1 | 5.7 | 21.8% | 13.7% | 0.16 | −9.2% | minus 19.4% |
| BAYERCROPBayer Cropscience | 3,316.30 | plus 0.48% | 14,904 | 20.0 | 15.4 | 27.9% | 16.0% | 0.03 | 3.6% | minus 31.7% |
| NACLINDNACL Industries | 117.21 | minus 12.67% | 2,746 | 234.4 | 29.0 | 6.9% | 8.5% | 0.46 | −9.1% | minus 32.7% |
| Median of 7 peers | – | −0.91% | 26,321 | 26.6 | 15.4 | 20.9% | 16.0% | 0.11 | 0.0% | −28.0% |
Quarterly results
| ₹ Cr | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|---|
| 201 | 448 | – | 318 | 361 | 383 | |
| – | – | – | – | +79.2% | minus 14.5% | |
| 275 | 410 | – | 312 | 348 | 342 | |
| −73.9 | 38.1 | – | 6.7 | 13.3 | 41.4 | |
| −36.7% | 8.5% | – | 2.1% | 3.7% | 10.8% | |
| 0.9 | 1 | – | 0.1 | 1.6 | 1.9 | |
| 14 | 13.8 | – | 12.4 | 7.2 | 6.1 | |
| 8 | 7.5 | – | 7.9 | 8.9 | 8.9 | |
| 29.3 | – | – | – | – | – | |
| −65.7 | 17.9 | – | −13.6 | −1.2 | 28.3 | |
| 23.9% | 27.2% | – | 25.3% | 27.7% | 26.4% | |
| −50 | 13 | – | −10.2 | −0.9 | 20.8 | |
| – | 0.60 | 0.12 | -0.47 | -0.04 | 0.89 |
Profit & loss
- Sales CAGR 3Y
- −9.1%
- Profit CAGR 3Y
- −63.6%
- EPS CAGR 3Y
- −63.7%
- ROE
- 0.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 2,097 | 1,756 | 1,213 | 1,573 | |
| – | minus 16.3% | minus 30.9% | +29.6% | |
| 1,898 | 1,747 | 1,283 | 1,492 | |
| 199 | 8.9 | −69.3 | 81.4 | |
| 9.5% | 0.5% | −5.7% | 5.2% | |
| −0.9 | 8.4 | 10.3 | 24.7 | |
| 36.3 | 60.6 | 52.8 | 39.9 | |
| 28.2 | 27.2 | 29.1 | 32 | |
| −5.5 | −5.7 | 21.7 | −24.7 | |
| 128 | −76.3 | −119 | 9.6 | |
| 26.1% | 22.8% | 22.7% | 52.2% | |
| 94.9 | −58.9 | −92.1 | 4.6 | |
| 4.38 | -2.71 | -4.27 | 0.21 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 19.9 | 19.9 | 20.1 | 23.4 | |
| 554 | 491 | 407 | 660 | |
| 724 | 789 | 399 | 312 | |
| 617 | 518 | 397 | 369 | |
| 1,915 | 1,818 | 1,223 | 1,364 | |
| 458 | 463 | 455 | 459 | |
| 57.9 | 29.5 | 23.5 | 9.9 | |
| 0 | 0 | 0 | 0 | |
| 41.5 | 32.3 | 57.3 | 2.7 | |
| 1,357 | 1,293 | 687 | 893 | |
| 1,915 | 1,818 | 1,223 | 1,364 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −20.4 | 50.4 | 469 | −104 | |
| −142 | −37.7 | 3.9 | −58.4 | |
| 135 | −21.8 | −448 | 108 | |
| −28.3 | −9.1 | 25 | −54.7 | |
| −146 | −39 | −33.4 | −30.3 | |
| −166 | 11.4 | 436 | −134 | |
| −11.9 | −5 | – | – |
Shareholding pattern
NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 0.0% (Yahoo estimate).
Major shareholders
Filings & events
News
No recent news coverage found.